• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA-1273 新冠病毒疫苗接种后出现自限性类风湿性多肌痛综合征。

Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination.

机构信息

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan.

出版信息

Intern Med. 2022 Mar 15;61(6):903-906. doi: 10.2169/internalmedicine.8829-21. Epub 2021 Dec 28.

DOI:10.2169/internalmedicine.8829-21
PMID:34980802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8987264/
Abstract

Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease characterized by stiffness and aching mainly in the shoulders, neck and hip girdles. The underlying pathogenesis of PMR involves myeloid lineage activation with a high expression of pattern recognition receptors. In addition, vaccination against severe acute respiratory syndrome coronavirus 2 with mRNA-1273 functions as both an immunogen and intrinsic adjuvant. It leads to the activation of innate immunity, resulting in antibody production. We herein report the first case of PMR-like syndrome seven days after mRNA-1273 vaccination. Reassuringly, the symptoms, such as pain of the neck, shoulder girdle and pelvic girdle, as well as elevated inflammatory markers were resolved within a month without glucocorticoid or immunosuppressant administration.

摘要

巨细胞动脉炎(PMR)是一种炎症性风湿性疾病,主要表现为肩部、颈部和髋部的僵硬和疼痛。PMR 的潜在发病机制涉及髓系细胞的激活,伴有模式识别受体的高表达。此外,mRNA-1273 对严重急性呼吸综合征冠状病毒 2 的疫苗接种既具有免疫原性,又具有内在佐剂作用。它导致先天免疫的激活,从而产生抗体。本文报告首例 mRNA-1273 接种后 7 天出现 PMR 样综合征。令人欣慰的是,颈部、肩部和髋部疼痛以及炎症标志物升高的症状在一个月内无需糖皮质激素或免疫抑制剂治疗即可缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93a/8987264/1149e2af0cdc/1349-7235-61-0903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93a/8987264/1149e2af0cdc/1349-7235-61-0903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93a/8987264/1149e2af0cdc/1349-7235-61-0903-g001.jpg

相似文献

1
Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination.mRNA-1273 新冠病毒疫苗接种后出现自限性类风湿性多肌痛综合征。
Intern Med. 2022 Mar 15;61(6):903-906. doi: 10.2169/internalmedicine.8829-21. Epub 2021 Dec 28.
2
Polymyalgia Rheumatica Following COVID-19 Vaccination.接种 COVID-19 疫苗后的巨细胞动脉炎。
Intern Med. 2022 Jun 1;61(11):1775-1777. doi: 10.2169/internalmedicine.8934-21. Epub 2022 Mar 26.
3
Polymyalgia rheumatica following COVID-19 vaccination: A case-series of ten patients.新冠病毒疫苗接种后发生的风湿性多肌痛:10例患者的病例系列报道
Joint Bone Spine. 2022 Mar;89(2):105334. doi: 10.1016/j.jbspin.2021.105334. Epub 2021 Dec 22.
4
Humoral SARS-CoV-2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster.巨细胞动脉炎和风湿性多肌痛患者对 SARS-CoV-2 体液疫苗的反应:初次接种后的衰减及加强针的效果
Arthritis Care Res (Hoboken). 2024 Jan;76(1):105-110. doi: 10.1002/acr.25173. Epub 2023 Aug 4.
5
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.接种 COVID-19 疫苗后的风湿性多肌痛和巨细胞动脉炎:一项全国性调查的结果。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2334084. doi: 10.1080/21645515.2024.2334084. Epub 2024 Apr 2.
6
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150.严重急性呼吸综合征冠状病毒2、风湿性多肌痛和巨细胞动脉炎:新冠疫苗接种会成为诱因吗?对曼佐等人所著《严重急性呼吸综合征冠状病毒2会引发风湿性多肌痛复发吗?》的评论。《关节与脊柱》2021年;88:105150
Joint Bone Spine. 2022 Jan;89(1):105282. doi: 10.1016/j.jbspin.2021.105282. Epub 2021 Sep 29.
7
New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine.辉瑞-生物科技 COVID-19 疫苗接种后新发巨细胞动脉炎。
Intern Med. 2022 Mar 1;61(5):749-753. doi: 10.2169/internalmedicine.8651-21. Epub 2021 Dec 11.
8
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group.感染 SARS-CoV-2 后或接种 COVID-19 疫苗后出现的炎症性风湿病:来自 COVID-19 和 ASD 组的 267 例报告。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003022.
9
[Polymyalgia rheumatica and aortic involvement].[风湿性多肌痛与主动脉受累]
G Ital Cardiol (Rome). 2014 May;15(5):306-12. doi: 10.1714/1563.17031.
10
[Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review].[风湿性多肌痛和颞动脉炎。病例报告与文献综述]
Minerva Med. 1987 Mar 15;78(5):287-96.

引用本文的文献

1
Polymyalgia rheumatica following COVID-19 vaccination: Case series of 3 patients and literature review on polymyalgia rheumatica induced by various vaccines.COVID-19 疫苗接种后的巨细胞动脉炎:3 例病例系列及各种疫苗引起的巨细胞动脉炎的文献复习。
Medicine (Baltimore). 2024 Oct 25;103(43):e40204. doi: 10.1097/MD.0000000000040204.
2
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.接种 COVID-19 疫苗后的风湿性多肌痛和巨细胞动脉炎:一项全国性调查的结果。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2334084. doi: 10.1080/21645515.2024.2334084. Epub 2024 Apr 2.
3

本文引用的文献

1
Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.新冠疫苗引发的免疫反应的差异动力学
N Engl J Med. 2021 Nov 18;385(21):2010-2012. doi: 10.1056/NEJMc2115596. Epub 2021 Oct 15.
2
Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study.新型冠状病毒肺炎疫苗接种后巨细胞动脉炎和风湿性多肌痛的风险:一项全球药物警戒研究
Rheumatology (Oxford). 2022 Feb 2;61(2):865-867. doi: 10.1093/rheumatology/keab756.
3
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150.
New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review.
截至2023年5月SARS-CoV-2疫苗接种后新发的风湿性免疫介导炎症性疾病:一项系统评价
Vaccines (Basel). 2023 Oct 8;11(10):1571. doi: 10.3390/vaccines11101571.
4
Nonepisodic Angioedema with Eosinophilia Following Receipt of the BNT162b2 mRNA COVID-19 Vaccine.接种 BNT162b2 mRNA COVID-19 疫苗后出现无发作性血管性水肿伴嗜酸性粒细胞增多。
Intern Med. 2023 Oct 15;62(20):3063-3067. doi: 10.2169/internalmedicine.1788-23. Epub 2023 Jul 19.
5
Impact of Different Isokinetic Movement Patterns on Shoulder Rehabilitation Outcome.不同等速运动模式对肩部康复效果的影响。
Int J Environ Res Public Health. 2022 Aug 25;19(17):10623. doi: 10.3390/ijerph191710623.
6
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature.风湿性多肌痛和多肌痛样综合征作为新冠病毒疫苗接种后的不良事件:来自已发表文献叙述性综述的工作笔记
Reumatologia. 2022;60(2):142-147. doi: 10.5114/reum.2022.115665. Epub 2022 May 18.
7
Polymyalgia Rheumatica After ChAdOx1 nCov-19 Vaccine: A Case Report.ChAdOx1 nCov-19疫苗接种后发生的风湿性多肌痛:一例报告
Cureus. 2022 May 26;14(5):e25346. doi: 10.7759/cureus.25346. eCollection 2022 May.
8
An update on polymyalgia rheumatica.关于巨细胞动脉炎的最新进展。
J Intern Med. 2022 Nov;292(5):717-732. doi: 10.1111/joim.13525. Epub 2022 Jun 11.
9
Cubital Tunnel Syndrome Temporally after COVID-19 Vaccination.新冠疫苗接种后出现的肘管综合征
Trop Med Infect Dis. 2022 Apr 16;7(4):62. doi: 10.3390/tropicalmed7040062.
严重急性呼吸综合征冠状病毒2、风湿性多肌痛和巨细胞动脉炎:新冠疫苗接种会成为诱因吗?对曼佐等人所著《严重急性呼吸综合征冠状病毒2会引发风湿性多肌痛复发吗?》的评论。《关节与脊柱》2021年;88:105150
Joint Bone Spine. 2022 Jan;89(1):105282. doi: 10.1016/j.jbspin.2021.105282. Epub 2021 Sep 29.
4
Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: A case report and review of literature.接种新冠疫苗后出现的罕见不良事件——风湿性多肌痛:一例病例报告及文献综述
Aging Med (Milton). 2021 Aug 15;4(3):234-238. doi: 10.1002/agm2.12171. eCollection 2021 Sep.
5
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.接种BNT162b2和mRNA-1273后新型冠状病毒2型抗体反应的比较
JAMA. 2021 Oct 19;326(15):1533-1535. doi: 10.1001/jama.2021.15125.
6
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.COVID-19 疫苗 mRNA-1273 在小鼠中引发了保护性免疫谱,而在 SARS-CoV-2 挑战时,这种免疫谱与疫苗增强疾病无关。
Immunity. 2021 Aug 10;54(8):1869-1882.e6. doi: 10.1016/j.immuni.2021.06.018. Epub 2021 Jul 2.
7
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.mRNA-1273 疫苗中 COVID-19 的过敏原成分:可能涉及聚乙二醇和 IgG 介导的补体激活。
Allergy. 2021 Nov;76(11):3307-3313. doi: 10.1111/all.14794. Epub 2021 Jun 17.
8
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
9
Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.接种流感疫苗后发生巨细胞动脉炎或风湿性多肌痛:12 例患者的研究及文献复习。
Autoimmun Rev. 2021 Feb;20(2):102732. doi: 10.1016/j.autrev.2020.102732. Epub 2020 Dec 14.
10
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛的监测和长期管理。
Nat Rev Rheumatol. 2020 Sep;16(9):481-495. doi: 10.1038/s41584-020-0458-5. Epub 2020 Aug 5.